Skip to main content
Clinical Trials/CTRI/2023/07/055119
CTRI/2023/07/055119Not yet recruitingUnknown

To evaluate the role of 1,3-Beta-D-Glucan for diagnosing invasive fungal infections in adults in ICU- a prospective observational study - Nil

Max Super Speciality Hospital0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Unknown
Status
Not yet recruiting

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Inclusion Criteria

  • 1)Candida Score >3 for Invasive Candidiasis OR
  • 2)Fulfilling Meersseman criteria for Invasive Aspergillosis

Exclusion Criteria

  • 1)Patients < 18 years
  • 2)Patients already on antifungal treatment
  • 3)Unwillingness to participate in study

Investigators

Similar Trials